Relationship of dose of hemodialysis and cause-specific mortality

Kidney International

Volumn 50, Issue 2, 1996, Pages 557-565

  Bloembergen, Wendy E ^a   Stannard, David C ^b   Port, Friedrich K ^b   Wolfe, Robert A ^b   Pugh, Jacqueline A ^b   Jones, Camille A ^b   Greer, Joel W ^b   Golper, Thomas A ^b   Held, Philip J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE MIX; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; HEART DISEASE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK;

EID: 0029789148     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.349     Document Type: Article

References (57)

1. BABB AL, STRAND MJ, UVELLI DA, MILUTINOVIC J, SCRIBNER BH: Quantitative description of dialysis treatment: A dialysis index. Kidney Int 2(Suppl 1):S523-S529, 1975
2. BABB AL, POPOVICH RP, CHRISTOPHER TG, SCRIBNER BH: The genesis of the square-meter-hour hypothesis. ASAIO Trans 17:80-91, 1971
3. KJELLSTRAND CM, EVANS RL, PETERSON RJ, SHIDEMAN JR, VONHARTISCH B, BUSELMEIR TJ: The "unphysiology" of dialysis: A major cause of dialysis side effects? Kidney Int 2(Suppl 1):S30-S34, 1975
4. TESCHAN PE, GINN HE, BOURNE JR, WARD JW, HAMEL B, NUNALLY JC, MUSSO M, VAUGHN WK: Quantitative indices of clinical uremia. Kidney Int 15:676-697, 1979
5. BOSL R, SHIDEMAN J, MEYER R, BUSELMEIER TJ, VON HARTITZSCH B, KJELLSTRAND CM: Effects and complications of high efficiency dialyzers. Nephrol 15:151-160, 1975
6. LAIRD NM, BERKEY CS, LOWRIE EG: Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 23(Suppl 13):S101-S106, 1983
7. PARKER TF: Trends and concepts in the prescription and delivery of dialysis in the United States. Semin Nephrol 12:267-275, 1992
8. GOTCH F, SARGENT J: A mechanistic analysis of the National Dialysis Study. Kidney Int 28:526-537, 1985
9. LOWRIE EG, LAIRD NM (EDS): The National Cooperative Dialysis Study. Kidney Int 23(Suppl 13):S1-S122, 1983
10. KESHAVIAH P: Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 43(Suppl 40):S28-S38, 1993
11. HELD PJ, PORT FK, WOLFE RA, STANNARD DC, CARROLL CE, DAUGIRDAS JT, BLOEMBERGEN WE, GREER JW, HAKIM RM: The dose of hemodialysis and patient mortality. Kidney Int 50:000-000, 1996
12. OWEN WF, LEW NL, LIU Y, LOWRIE EG, LAZARUS JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
13. COLLINS A, LIAO M, UMEN A, HANSON G, KESHAVIAH P: Diabetic hemodialysis patients treated with a high Kt/V have a lower risk of death than standard Kt/V. J Am Soc Nephrol 2:318, 1991
14. SCHLEIFER CR, SNYDER S, JONES K: The influence of urea kinetic modeling on gross mortality in hemodialysis. (abstract) J Am Soc Nephrol 2:349, 1991
15. ACCHIARDO SR, RUNYAN K, HATTEN KW, DYSON B, FULLER J, MOORE L: Impact of Kt/V and protein catabolic rate on hemodialysis mortality. (abstract) J Am Soc Nephrol 3:351, 1992
16. HAKIM RM, BREYER J, ISMAIL N, SCHULMAN G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994
17. COLLINS A, KESHAVIAH P, MA J, UMEN A: Elderly dialysis patients have a lower risk of cardiac infectious, and all deaths with a Kt/V ≥ 1.2 for non-diabetics and Kt/V ≥ 1.4 for diabetic patients. (abstract) ASAIO Abstr 22:79, 1993
18. HELD PJ, PORT FK, GARCIA J, GAYLIN DS, LEVIN NW, AGODOA L: Hemodialysis prescription and delivery in the U.S.: Results from USRDS Case Mix Study. (abstract) J Am Soc Nephrol 2:328, 1991
19. JINDAL KK, MANUEL A, GOLDSTEIN MB: Percent reduction in blood urea concentration during hemodialysis (PRU): A simple and accurate method to estimate Kt/V urea. ASAIO Trans 33:286-288, 1987
20. DAUGIRDAS JT: Bedside formulas for Kt/V: A kinder gentler approach to urea kinetic modeling. ASAIO Trans 35:336-338, 1989
21. FLANIGAN MJ, FANGMAN J, LIM VS: Quantitating hemodialysis: A comparison of three kinetic models. Am J Kid Dis 17:295-302, 1991
22. DAUGIRDAS JT: Second generation logarithmic estimates of single-pool variable volume of Kt/V: An analysis of error. J Am Soc Nephrol 4:1205-1213, 1993
23. LOWRIE EG, LEW NL: The urea reduction ratio (URR): A simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol 12:11-20, 1991
24. Cox D: Regression models and life tables. J Royal Stat Soc 34:187-201, 1972
25. WOLFE RA, PORT FK, HAWTHORNE VM, GUIRE KE: A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous ambulatory peritoneal dialysis at home. Am J Kidney Dis 15:433-440, 1990
26. UMEN AJ, LE CT: Prognostic factors, models and related statistical problems in the survival of endstage renal disease patients on hemodialysis. Stat Med 5:637-652, 1986
27. SAS INSTITUTE INC.: SAS* Technical Report P-229, SAS/STAT* Software: Changes and Enhancements, Release 6.07, Cary, NC, SAS Institute Inc., 1992
28. KALBFLEISCH JD, PRENTICE RL: The Statistical Analysis of Failure Time Data. New York, Wiley, 1980
29. LINDNER A, CHARRA B, SHERRARD DJ, SCRIBNER BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
30. LAZARUS JM, LOWRIE EG, HAMPERS CL, MERRILL JP: Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 7(Suppl 2): S167-S175, 1975
31. PARSONS FM, BRUNNER FP, GURLAND HJ, HARLEN H: Combined report of regular dialysis and transplanation in Europe. Proc Eur Dial Transplant Assoc 8:3-27, 1971
32. IBELS LS, STEWART JH, MAHONY JF, NEALE FC, SHEIL AGR: Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. Q J Med 46:197-214, 1977
33. RITZ E, KOCH M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kid Dis 21(Suppl 2):113-118, 1993
34. NICHOLLS A: Atherosclerosis in chronic renal failure: a historical perspective. Scott Med J 28:270-275, 1983
35. NICHOLLS AJ, CATTO GRD, EDWARD N, ENGESET J, MACLEOD M: Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: Fact or fiction? Lancet 1:276-278, 1980
36. BURKE JF, FRANCOS GC, MOORE LL, CHO SY, LASKER N: Accelerated atherosclerosis in chronic-dialysis patients - Another look. Nephron 21:181-185, 1978
37. ROSTAND SG, GRETES JC, KIRK KA, RUTSKY EA, ANDREOLI TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-611, 1979
38. ROSTAND SG, KIRK KA, RUTSKY EA: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22:304-308, 1982
39. CHEIGH JS, MILITE C, SULLIVAN J, RUBIN AL, STENZEL KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kid Dis 19:453-459, 1992
40. CHARRA B, CLAEMARD E, RUFFET M, CHAZOT C, TERRAT JC, VANEL T, LAURENT G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
41. UNITED STATES RENAL DATA SYSTEM: USRDS 1995 Annual Data Report. Bethesda, National Institute of Diabetes and Digestive and Kidney Diseases, 1995
42. ROODVOETS AP, NEERBOS BR, VAN HOOGHWINKEL GJM, HULSMANS HAM, BUEKERS H: Hyperlipidemia in patients on regular dialysis. Proc Eur Dial Transplant Assoc 4:257-263, 1967
43. BAGDADE JD: Chronic renal failure and atherogenesis. Atherosclerosis 34:243-248, 1979
44. PIERIDES AM, WEIGHTMAN D, GOLDFINCH M, ALJAMA P, KERR DNS: Hyperlipidemia of regular hemodialysis and successful transplantation. Cardiovasc Med 3:185-206, 1978
45. HAFFNER SM, GRUBER KK, ALDRETE G, MORALES PA, STERN MP, TUTTLE KR: Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol 3:1156-1162, 1992
46. SERES DS, TRAIN GW, HASHIM SA, GOLDBERG IJ, LEVIN NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3:1409-1415, 1993
47. JOSEPHSON MA, FELLNER SK, DASGUPTA A: Improved lipid profiles in patients undergoing high-flux hemodialysis. Am J Kidney Dis 20:361-366, 1992
48. LOUGHREY CM, JACKSON PC, MCGINTY A, MCENENY J, YOUNG IS: Cytotoxicity of carbamylated LDL cholesterol to human fibroblasts. (abstract) J Am Soc Nephrol 5:496, 1994
49. COHEN BD, PATEL H, KORNHAUSER RS: Alternate reasons for atherogenesis in uremia. Proc Dial Transplant Forum 7:178-180, 1977
50. MURASE T, CATTRAN DC, RUBENSTEIN B, STEINER G: Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 24:1279-1286, 1975
51. VANHOLDER R, RINGOIR S: Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review. J Am Soc Nephrol 3:1541-1554, 1993
52. LINDSAY RM, SPANNER E, HEIDENHEIM P, LEFEBRE JM, HODSMAN A, BAIRD J, ALLISON MEM: Which comes first, Kt/V or PCR- Chicken or egg? Kidney Int 42(Suppl 38):S32-S36, 1992
53. LINDSAY RM, HEIDENHEIM P, SPANNER E, KORTAS C, BLAKE PG: Adequacy of hemodialysis and nutrition- Important determinants of morbidity and mortality. Kidney Int 45(Suppl 44):S85-S91, 1994
54. CHURCHILL DN, TAYLOR W, COOK RJ, LA PLANTE P, BARRE P, CARTIER P, FAY WP, GOLDSTEIN MB, JINDAL K, MANDIN H, MCKENZIE JK, MUIRHEAD N, PARFREY PS, POSEN GA, SLAUGHTER D, ULAN RA, WERB R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234, 1992
55. UNITED STATES RENAL DATA SYSTEM: Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis. Am J Kid Dis 5(Suppl 2):20-26, 1992
56. LOWRIE EG, LEW HL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kid Dis 15:458-482, 1990
57. LYSAGHT MJ, VONESH EF, GOTCH F, IBELS L, KEEN M, LINDHOLM B, NOLPH KD, POLLACK CA, PROWANT B, FARRELL PC: The influence of dialysis treatment modality on the decline of remaining renal function. Trans ASAIO 37:598-604, 1991